Evidence map›Paper›PMID 29863145›Full record

ReviewAnnals of gastroenterological surgery2018

Recent updates in the surgical treatment of colorectal cancer.

Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Taro Oshikiri, Masayoshi Hosono, Nobuhide Higashino, Masashi Yamamoto, Yoshiko Matsuda, Shingo Kanaji, Tetsu Nakamura and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Digestive cancers: mechanisms, therapeutics and management.Signal transduction and targeted therapy · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Takeru MatsudaDivision of Minimally Invasive Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID 0000-0002-9541-856X
Kimihiro YamashitaDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Hiroshi HasegawaDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Taro OshikiriDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Masayoshi HosonoDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Nobuhide HigashinoDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Masashi YamamotoDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Yoshiko MatsudaDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Shingo KanajiDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID 0000-0002-8698-8923
Tetsu NakamuraDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Satoshi SuzukiDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.ORCID 0000-0002-7287-6998
Yasuo SumiDivision of International Clinical Cancer Research Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Yoshihiro KakejiDivision of Gastrointestinal Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan.
Kobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of recent advances in medical technology and new findings of clinical trials, treatment options for colorectal cancer are evolutionally changing, even in the last few years. Therefore, we need to update the treatment options and strategies so that patients can receive optimal and tailored treatment. The present review aimed to elucidate the recent global trends and update the surgical treatment strategies in colorectal cancer by citing the literature published in the last 2 years, namely 2016 and 2017. Although laparoscopic surgery is still considered the most common approach for the treatment of colorectal cancer, new surgical technologies such as transanal total mesorectal excision, robotic surgery, and laparoscopic lateral pelvic lymph node dissection are emerging. However, with the recent evidence, superiority of the laparoscopic approach to the open approach for rectal cancer seems to be controversial. Surgeons should notice the risk of adverse outcomes associated with unfounded and uncontrolled use of these novel techniques. Many promising results are accumulating in preoperative and postoperative treatment including chemotherapy, chemoradiotherapy, and targeted therapy. Development of new biomarkers seems to be essential for further improvement in the treatment outcomes of colorectal cancer patients.

Indexed as

colorectal cancerlaparoscopic surgerylateral pelvic lymph node dissectionrobotic surgerytransanal total mesorectal excision

Identifiers

PMID29863145
PMCPMC5881369
OpenAlexW2794024457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.